(Q34206750)

31 July 2017

title

Estrogen fluctuations, oral contraceptives and borderline personality (English)

1 reference

borderline personality disorder

31 July 2017

main subject

0 references

2

David C Geary

1 reference

31 July 2017

3

Mary K Hoard

1 reference

31 July 2017

M Catherine DeSoto

1

1 reference

31 July 2017

Melanie S Sheldon

series ordinal

4

1 reference

31 July 2017

Lynn Cooper

series ordinal

5

1 reference

31 July 2017

publication date

1 August 2003

1 reference

31 July 2017

published in

Psychoneuroendocrinology

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

751-766

1 reference

Ovarian steroids and serotonin neural function

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Estrogens and relationship jealousy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

A comparison of the effect of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Gender differences in personality disorders in psychiatrically hospitalized adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Serotonergic sensitivity in borderline personality disorder: preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Serotonin metabolite excretion after postmenopausal estradiol therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Neuroendocrine study of serotonin function in female borderline personality disorder patients: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Estrogen-serotonin interactions: implications for affective regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Assessing estradiol in biobehavioral studies using saliva and blood spots: simple radioimmunoassay protocols, reliability, and comparative validity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

A twin study of personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Pathways to the development of borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

Borderline personality disorder features in nonclinical young adults: 2. Two-year outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900068-9

7 January 2021

10.1016/S0306-4530(02)00068-9

Identifiers

DOI

1 reference

31 July 2017

1 reference